Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 (hospitalized or not) meta-analysis

NCT04429711 (Biber)
RCTivermectinplaceboCOVID-19 (hospitalized or not)some concern
-/- suggested
  • suggested 1.6-fold increase in viral clearance by day 7 (PE) with a moderate degree of certainty due to some concern in risk of bias

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).